Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Volume just skyrocketed

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Sep 23, 2021 2:34pm

118 Views

Post# 33908499

RE:RE:RE:RE:RE:Volume just skyrocketed

Of course, the big question is how much of this will hold on for a month or two. Likely only a bit, but it's nice!

Wino115 wrote: I saw it. It was very brief but he did a good job stating it's a hidden gem and spoke about cancer only.

SPCEO1 wrote: What an incredibly crazy stock market we have now. This is beccause of my friend recommending the stock on Fox Business News. I did not have a chance to watch it but he must have sold the story well.

Maybe this will finally convince TH that paying attention to the retail investor pays dividends.

JasontheGreat wrote: Whoa! Is this on any news?